Industry News
Pharmaceutical Industry News
The highly debatable HARMONi data,…
The highly debatable HARMONi data, along with the trial design flaws and the unfortunate execution they reflect, plus a rapidly evolving competitive landscape, all point to one conclusion: Summit must partner with a Big Pharma
U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
To really move the needle and…
To really move the needle and reach consumers, it’s critical that ad spots come with a clear sense of authenticity and relatability in addition to the glitz and glam of Hollywood fame, experts said during
Industry media leads joined a…
Industry media leads joined a Fierce Pharma Week panel to discuss their shifting communication strategies amid an unfamiliar and turbulent political and policy era.
Sanofi has formed a “celebrity…
Sanofi has formed a “celebrity mom squad” to promote immunization against respiratory syncytial virus. The troupe of celebrity endorsers features actor-singer Mandy Moore and four other famous moms who are using Sanofi’s Beyfortus to help
President Donald Trump has…
President Donald Trump has delivered another blow in his ongoing battle with the pharma industry, signing a memorandum on Tuesday that directs the FDA to rein in direct-to-consumer (DTC) drug advertising.
How Gen Z Protests Overturned a Government, and a Crackdown on TV Drug Ads
Plus, 7-Eleven’s new master plan.
The drug-releasing system combo is…
The drug-releasing system combo is approved to treat patients with bladder cancer who face removal of the organ after not responding to the standard-of-care Bacillus Calmette-Guérin treatment in the first-line setting.
In a bid to save around 8 billion…
In a bid to save around 8 billion Danish kroner ($1.3 billion) annually by the end of 2026, Novo will lay off roughly 9,000 employees across its global workforce of 78,400. Some 5,000 job cuts
Six months after Walgreens and…
Six months after Walgreens and three other retailers brought an antitrust lawsuit against Takeda and TWi Pharmaceuticals over an alleged “pay-for-delay” scheme, CVS has filed a similar antitrust complaint against the same companies.
Eli Lilly has partnered with…
Eli Lilly has partnered with Julianne Moore, tapping into the actor’s experience in the movie “Still Alice” to encourage people to prioritize brain health.
Trump Moves to Crack Down on Drug Advertising
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
RFK Jr. Releases Childhood Health Report
The report, which follows a draft leaked last month, demonstrates both the ambitions and limits of Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.
Ahead of New York Fashion Week,…
Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary cholangitis.
Policy recommendations released…
Policy recommendations released Tuesday by the RFK Jr.-led commission were light on details but included plans to ramp up research and potential oversight on some of the secretary's more controversial focus areas.
In a keynote session Tuesday at…
In a keynote session Tuesday at the Fierce Pharma Week 2025 conference in Philadelphia, Sigler spoke about the decision to open up about her MS diagnosis, the positive impacts it’s had on her life and
Effective Tuesday, Ryan Quigley…
Effective Tuesday, Ryan Quigley has stepped into the CEO role at Inizio. He’s succeeding Paul Taaffe, who has served as chief executive since Inizio’s 2022 founding.
Lundbeck is making a big push on…
Lundbeck is making a big push on the company’s capital reallocation initiative, handing over its operations in 27 markets to partners.
Regeneron and Sandoz have reached…
Regeneron and Sandoz have reached a settlement that resolves all patent litigation related to the Swiss company’s biosimilar version of eye disease drug Eylea.
The private equity firm is looking…
The private equity firm is looking to attract other private equity buyers to take on the CDMO for a valuation of up to $4 billion, the Financial Times reported on Sept. 6.